Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aspire-Lakewood HoldingsASBP +2.42%11 PS Ratio is 28.73 as of Sep. 11, 2026, which is 90% below its 10-year median of 294.83. GuruFocus rates ASBP with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 936 Biotechnology companies, Aspire-Lakewood Holdings ranks worse than 71.26% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Aspire-Lakewood Holdings's share price is $9.25.
Aspire-Lakewood Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $0.32. Hence, Aspire-Lakewood Holdings's PS Ratio for today is 28.73.
The historical rank and industry rank for Aspire-Lakewood Holdings's PS Ratio or its related term are showing as below:
ASBP'
s PS Ratio Range Over the Past 10 Years
Min: 18.66 Med: 294.83 Max: 9399.18
Current: 28.35
During the past 4 years, Aspire-Lakewood Holdings's highest PS Ratio was 9399.18. The lowest was 18.66. And the median was 294.83.
ASBP's PS Ratio is ranked worse than 71.26% of 936
companies
in the Biotechnology industry
Industry Median: 9.545
vs ASBP: 28.35
Aspire-Lakewood Holdings (NAS:ASBP) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Aspire-Lakewood Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aspire-Lakewood Holdings PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aspire-Lakewood Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where Aspire-Lakewood Holdings's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Aspire-Lakewood Holdings's Share Price of today is $9.25. Aspire-Lakewood Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.32.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Aspire-Lakewood Holdings (ASBP) has a PS Ratio of 28.73 as of Sep. 11, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aspire-Lakewood Holdings and its competitors. This is 90% below median its historical median of 294.83. Over the past decade, Aspire-Lakewood Holdings' PS Ratio has ranged from 18.66 to 9,399.18. According to the industry distribution chart, Aspire-Lakewood Holdings ranks #667 out of 936 companies in the Biotechnology industry, placing it in the top 71.3%.
Is Aspire-Lakewood Holdings' PS Ratio too high?
Aspire-Lakewood Holdings' current PS Ratio of 28.73 is 90% below median its 10-year median of 294.83. Over the past 10 years, this metric has ranged from a low of 18.66 to a high of 9,399.18. The Biotechnology industry median PS Ratio is 9.55. Aspire-Lakewood Holdings' value of 28.73 is 201% above this industry median. Based on the distribution chart, Aspire-Lakewood Holdings ranks #667 out of 936 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Aspire-Lakewood Holdings has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Aspire-Lakewood Holdings' PS Ratio compare to PDSB and KPRX?
According to the Biotechnology industry distribution chart, Aspire-Lakewood Holdings ranks #667 out of 936 companies for PS Ratio. This places Aspire-Lakewood Holdings in the lower half of its industry. The industry median PS Ratio is 9.55. Aspire-Lakewood Holdings' value of 28.73 is 201% above this benchmark. Historically, Aspire-Lakewood Holdings' own PS Ratio has ranged from 18.66 to 9,399.18 over the past decade. While the company's 10-year median is 294.83 vs. the industry median of 9.55, Aspire-Lakewood Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.55, based on 936 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aspire-Lakewood Holdings's current PS Ratio of 28.73 is 201% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aspire-Lakewood Holdings and its competitors. For the Biotechnology industry, the median PS Ratio is 9.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aspire-Lakewood Holdings's current PS Ratio is 28.73, which is 90% below median its own 10-year median of 294.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspire-Lakewood Holdings stock overvalued right now?
Aspire-Lakewood Holdings (ASBP) has a current PS Ratio of 28.73. The current PS Ratio is 28.73, which is 90% below median its 10-year median of 294.83 and 201% above the Biotechnology industry median of 9.55. Aspire-Lakewood Holdings' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Aspire-Lakewood Holdings (ASBP), the current PS Ratio is 28.73 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
11GF Score
Get the complete analysis for ASBP
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASBP has been successfully added to your 
